COVID-19 Resources and Services from WCG:
COVID-19 Webinar Series
Watch the WCG COVID-19 Webinar Series On-Demand
Join thousands of your peers in watching WCG’s webinar series, where clinical trial and public health experts provide the insights on COVID-19 and discuss the biggest questions and topics you submit.
COVID-19 Clinical Trial Tracker
Monitor the progress of clinical trials for COVID-19 treatments and vaccines, leveraging data from the WCG Knowledge Base™.
COVID-19 Trial Insights from the WCG Knowledge Base™
About WCG Trial Insights
The WCG Trial Insights series brings you weekly insights on trial activity throughout the COVID-19 crisis, based on the extensive services we provide to life science clients and supported by our proprietary and powerful WCG Knowledge Base™.
WCG COVID-19 Advisory Services
Need help interpreting critical data to navigate the impact of COVID-19 on trials and sites? We leverage insights and benchmark data from the WCG Knowledge Base to guide best practices for trial performance during this unprecedented time.
Insights from June 11, 2021
Recent Insights from WCG
The map below displays WCG locations. The same locations are listed below the map.
Watch Recent COVID-19 Webinars
Recent news on COVID-19 and clinical trials
News provided by WCG FDAnews and WCG CenterWatch
FDA Appears Ready to Ask Pfizer-BioNTech for More Studies on its COVID-19 Booster Shot Friday — Days Before Biden Wants to Begin Distribution
The FDA has indicated that it will be asking Pfizer-BioNTech to perform more studies on the COVID-19 vaccine Comirnaty’s booster shot before approving the companies’ supplemental biologics license application (BLA).
CBER Director Marks Says COVID-19 Boosters May Be Needed
COVID-19 vaccine booster shots may be necessary to sustain waning immunity, said Center for Biologics Evaluation and Research (CBER) Director Peter Marks in remarks at the RAPS Convergence annual conference, which is being held virtually this week because of the pandemic.
Emergent to Produce COVID-19 Vaccine for Providence Therapeutics
Gaithersburg, Md.-based Emergent BioSolutions has struck a five-year deal with Providence Therapeutics to help manufacture the Canadian company’s COVID-19 vaccine candidate.
CureVac Downsizes COVID-19 Vaccine Manufacturing
CureVac said that its production deals with Rentschler Biopharma and Novartis will remain in place.
FDA and WHO Vaccine Experts Argue Against COVID-10 Boosters for the General Public
Two outgoing vaccine experts at the FDA as well as experts from the World Health Organization (WHO) are arguing that providing COVID-19 booster shots to the general public isn’t warranted at this time.
Moderna Developing Single-Dose Booster for COVID-19, Flu
Moderna is working on a new booster vaccine, mRNA-1073, that combines the drugmaker’s COVID-19 shot with its experimental flu vaccine in a single dose.
Novavax Begins Early-Stage Trial for Flu, COVID-19 Combo Vaccine
Results are expected during the first half of next year.
Exscientia, Gates Foundation Invest $70 Million Into COVID-19 Antivirals
“We need to fight today’s pandemic but also ensure we are prepared with new drugs to combat viruses with future pandemic potential,” said Exscientia CEO Andrew Hopkins.
Sinovac’s COVID-19 Booster Shot Shows Improved Activity Against Delta Variant
Neutralizing antibody activity against Delta was not observed in samples obtained from vaccinated individuals six months following a second dose, the researchers said.
Next-Gen COVID-19 Vaccine Trials Need an Active Comparator or Some Design Ingenuity
Approved vaccines and the diminishing numbers of unexposed individuals are making placebo-controlled trials for COVID-19 vaccines a thing of the past, so researchers will have to rely on active comparators to develop second-generation shots.
FDA and CDC Urge White House to Downsize Sept. 20 Booster Vaccine Rollout Plan
The Biden administration’s plan for a Sept. 20 rollout of vaccine booster shots may be delayed as the FDA and the Centers for Disease Control and Prevention (CDC) consider the available data for the Pfizer/BioNTech, Moderna and Johnson & Johnson (J&J) boosters.
Biden Administration Plans $3 Billion Investment in Vaccine Supply Chain
The Biden administration has pledged to pour almost $3 billion into beefing up domestic COVID-19 vaccine manufacturing as it considers a potential mass program of booster shots.
Expert insights on clinical trials and COVID-19
As we navigate COVID-19 together, our clinical trial experts are engaged to address the biggest questions. To submit a topic or question, use the form at the bottom of the page.
Submit a COVID-19 question or topic to be considered in future webinars
Please note: protocol-specific questions for studies under the oversight of a WCG IRB should be submitted through your IRB contact person, not through this form.
Disclaimer: All information available on this site is intended for your general knowledge and is not for the purpose of providing regulatory advice, medical advice, or a substitute for institutional review board review. You should not use this information to determine compliance with any applicable laws or regulations governing institutional review boards and human subjects research.